West Pharmaceutical Services, Inc.
392.15USD
-1.8800 (-0.48%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on WST.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.2▲ | $2.18 | 1 | 0 |
| Next quarter | $2.27▲ | $2.27 | 4 | 3 |
| Current year | $8.96▲ | $8.95 | 1 | 0 |
| Next year | $9.98▲ | $9.92 | 2 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.08 | $2.37 | +0.29 (+13.9%) |
| 2026-03-31 | $1.68 | $2.13 | +0.45 (+27.1%) |
| 2025-12-31 | $1.83 | $2.04 | +0.21 (+11.5%) |
| 2025-09-30 | $1.71 | $1.96 | +0.25 (+14.6%) |
84 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $410 $420 | Oct 13, 2026 |
| Barclays | Maintained | Overweight | $400 $440 | Oct 7, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $365 $400 | Sep 22, 2026 |
| UBS | Maintained | Buy | $340 $415 | Sep 9, 2026 |
| Citigroup | Maintained | Buy | $400 $412 | Aug 3, 2026 |
| Evercore ISI Group | Maintained | Outperform | $410 $425 | Jul 27, 2026 |
| BNP Paribas | Initiated | Outperform | $447 | Jul 13, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $325 $365 | Jul 9, 2026 |
| Evercore ISI Group | Maintained | Outperform | $390 $410 | Jul 6, 2026 |
| Keybanc | Maintained | Overweight | $350 $390 | Jul 2, 2026 |
| Barclays | Upgraded from Equal-Weight | Overweight | $310 $400 | Jun 9, 2026 |
| Stephens & Co. | Reiterated | Overweight | $360 | Jun 2, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $315 $325 | May 29, 2026 |
| Barclays | Maintained | Equal-Weight | $275 $310 | Apr 27, 2026 |
| Barclays | Maintained | Equal-Weight | $265 $275 | Apr 14, 2026 |
| Barclays | Maintained | Equal-Weight | $325 $265 | Feb 13, 2026 |
| Evercore ISI Group | Maintained | Outperform | $390 $320 | Feb 3, 2026 |
| Morgan Stanley | Initiated | Equal-Weight | $285 | Dec 2, 2025 |
| TD Cowen | Initiated | Buy | $350 | Oct 29, 2025 |
| Barclays | Maintained | Equal-Weight | $275 $325 | Oct 27, 2025 |
| UBS | Maintained | Buy | $320 $355 | Oct 24, 2025 |
| Keybanc | Maintained | Overweight | $325 $350 | Oct 24, 2025 |
| Evercore ISI Group | Maintained | Outperform | $350 $390 | Oct 23, 2025 |
| Barclays | Maintained | Equal-Weight | $260 $275 | Oct 2, 2025 |
| Rothschild & Co | Initiated | Buy | $311 | Sep 15, 2025 |
75 filings from 24 insiders · 16 buy / 4 sell over 6m
Officers and directors of WST, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HAUGEN JANET BRUTSCHEADirector | GrantPhantom Stock Unit | 44 | $370.76 | $16k | Sep 30, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Exercise | 2.5k | $89.64 | $226k | Sep 15, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Sell | 2.5k | $365.00 | $921k | Sep 15, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | ExerciseStock Option (Right to Buy) | 2.5k | — | — | Sep 15, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Exercise | 2.5k | $89.64 | $224k | Sep 14, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Sell | 2.5k | $355.00 | $888k | Sep 14, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | ExerciseStock Option (Right to Buy) | 2.5k | — | — | Sep 14, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Exercise | 2.5k | $89.64 | $224k | Sep 11, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Sell | 2.5k | $345.00 | $863k | Sep 11, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | ExerciseStock Option (Right to Buy) | 2.5k | — | — | Sep 11, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Exercise | 2.8k | $83.47 | $235k | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Sell | 2.8k | $340.81 | $960k | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Exercise | 2.8k | $83.47 | $235k | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Sell | 2.8k | $340.81 | $960k | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Exercise | 2.5k | $89.64 | $224k | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | Sell | 2.5k | $340.81 | $852k | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | ExerciseStock Options (Right to Buy) | 2.8k | — | — | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | ExerciseStock Options (Right to Buy) | 2.8k | — | — | Sep 8, 2026 |
| Favorite Annette FOfficer, Sr. VP & Chief HR Officer | ExerciseStock Option (Right to Buy) | 2.5k | — | — | Sep 8, 2026 |
| Lagarde MichelDirector; Officer, President and CEO | GrantStock Option (Right to Buy) | 13.9k | — | — | Sep 8, 2026 |
No analyst notes on WST yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 12 | 0 | 0 | 1 | Buy2.00 |
| 1 mo ago | 4 | 12 | 1 | 0 | 0 | Buy1.82 |
| 2 mo ago | 3 | 11 | 2 | 0 | 0 | Buy1.94 |
| 3 mo ago | 3 | 11 | 2 | 0 | 0 | Buy1.94 |
Members whose judged calls on WST have played out most reliably.
No settled calls on WST yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice